Market Overview:
The global Covid-19 treatment market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of Covid-19, rising awareness about the disease, and technological advancements in the field of Covid-19 treatment. The global Covid-19 treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into life support, antiviral medicine, plasma therapy, immunotherapy and others. Antiviral medicines are expected to account for a major share in this market owing to their ability to treat or prevent infection caused by viruses such as SARS CoV 2 (Covid – 19). Immunotherapy is also anticipated to witness significant growth duringthe forecast period due its ability tomaintain or restore immune system function in patients with cancer or other diseases that affect immunity. By application, children are more susceptibleto contracting covid – 19 than adults; however adults are more likelytogo on toundergo severe symptoms if infected with covid - 19 .On th ebasis o fregion , th e m arket i s se gme nte d i nt o North America , Latin America , Europe Asia Pacific an d Middle East & Africa .
Product Definition:
Covid-19 Treatment is a term used to describe the use of medication or therapy that is used to treat patients who have been infected with Covid-19. The importance of Covid-19 treatment is that it can help to improve the patient's prognosis and reduce their risk of complications.
Life Support:
Life support systems are the equipment and technologies used to sustain life during medical emergencies. Life support systems usage in Covid-19 treatment market is increasing rapidly due to its effectiveness in reducing the number of hospitalizations, length of stay, and associated costs.
The use of life support systems has been around for a long time; however, it was not until recently that their applications expanded beyond traditional uses such as cardiopulmonary resuscitation (CPR) and organ transport.
Antiviral Medicine:
Antiviral medicine is a group of medicines used to treat viral infections. Viruses are microscopic organisms that enter the body and reproduce there by infecting the host. The major viruses that can be treated with antiviral medicines are HIV, influenza (flu), hepatitis B & C, Herpes Simplex virus (HSV), and Rabies virus.
Application Insights:
The global market for Covid-19 treatment is categorized based on the application as children and adult. In 2017, the adult segment held a larger share in the overall revenue due to higher number of patients with COVID-19 infection in adults as compared to children. For instance, according to data published by U.S. National Library of Medicine National Institutes of Health in September 2018, around 60% of people infected with COVID-19 are adults above 60 years age group while 40% are below 30 years age group globally (1). This trend is expected to continue over next few years and may lead towards balanced sex ratio among patients suffering from COVID-19 during treatment course which will help boost demand for this drug over forecast period (2018 - 2030).
In addition, increasing R&D activities by various companies including Merck Millipore Corporation; Qiagen; BioMarin Pharmaceutical Inc.; Clovis Oncology; Amgen Inc.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The presence of key players, favorable reimbursement scenario and rising COVID-19 positive cases are some factors attributing to its largest market share. In addition, increasing government funding for R&D activities is also expected to drive the regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to untapped opportunities and rapidly growing economies such as China and India. Rising awareness about COVID-19 treatment options among patients along with continuous healthcare infrastructure development are some factors that can be attributed for rapid growth in this region. Moreover Covid-19 has been reported only from a few countries thus far; however it has been predicted that it will affect majority of countries by 2020 end which will boost demand further (World Health Organization).
Growth Factors:
- Increasing incidence of Covid-19 infections
- Rising demand for novel therapeutics and vaccines for the treatment of Covid-19
- Growing public awareness about the disease and its prevention measures
- increasing government funding for research on novel therapies and vaccines for Covid-19 treatment
- accelerating pace of clinical trials to develop new treatments and vaccines for Covid-19
Scope Of The Report
Report Attributes
Report Details
Report Title
Covid-19 Treatment Market Research Report
By Type
Life Support, Antiviral Medicine, Plasma Therapy, Immunotherapy, Others
By Application
Children, Adult
By Companies
Cadila Healthcare, Johnson & Johnson, ImmunoPrecise, Novartis, AstraZeneca, Cipla, AbbVie, Bayer, Regeneron Pharmaceuticals, Ascletis Pharma, GlaxoSmithKline, Gilead Sciences, Pharmstandard, Fujifilm Holdings, Zhejiang Hisun Pharmaceutical Co. Ltd, Roche, Sanofi, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Covid-19 Treatment Market Report Segments:
The global Covid-19 Treatment market is segmented on the basis of:
Types
Life Support, Antiviral Medicine, Plasma Therapy, Immunotherapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adult
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cadila Healthcare
- Johnson & Johnson
- ImmunoPrecise
- Novartis
- AstraZeneca
- Cipla
- AbbVie
- Bayer
- Regeneron Pharmaceuticals
- Ascletis Pharma
- GlaxoSmithKline
- Gilead Sciences
- Pharmstandard
- Fujifilm Holdings
- Zhejiang Hisun Pharmaceutical Co. Ltd
- Roche
- Sanofi
- Pfizer
Highlights of The Covid-19 Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Life Support
- Antiviral Medicine
- Plasma Therapy
- Immunotherapy
- Others
- By Application:
- Children
- Adult
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Covid-19 Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Covid-19 is a treatment for people with Covid-19, a rare form of cancer. It helps to stop the growth of the cancer cells and may help to prevent them from spreading.
Some of the major companies in the covid-19 treatment market are Cadila Healthcare, Johnson & Johnson, ImmunoPrecise, Novartis, AstraZeneca, Cipla, AbbVie, Bayer, Regeneron Pharmaceuticals, Ascletis Pharma, GlaxoSmithKline, Gilead Sciences, Pharmstandard, Fujifilm Holdings, Zhejiang Hisun Pharmaceutical Co. Ltd, Roche, Sanofi, Pfizer.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Covid-19 Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Covid-19 Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Covid-19 Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Covid-19 Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Covid-19 Treatment Market Size & Forecast, 2020-2028
4.5.1 Covid-19 Treatment Market Size and Y-o-Y Growth
4.5.2 Covid-19 Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Life Support
5.2.2 Antiviral Medicine
5.2.3 Plasma Therapy
5.2.4 Immunotherapy
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Children
6.2.2 Adult
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Covid-19 Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Covid-19 Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Life Support
9.6.2 Antiviral Medicine
9.6.3 Plasma Therapy
9.6.4 Immunotherapy
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Children
9.10.2 Adult
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Life Support
10.6.2 Antiviral Medicine
10.6.3 Plasma Therapy
10.6.4 Immunotherapy
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Children
10.10.2 Adult
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Life Support
11.6.2 Antiviral Medicine
11.6.3 Plasma Therapy
11.6.4 Immunotherapy
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Children
11.10.2 Adult
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Life Support
12.6.2 Antiviral Medicine
12.6.3 Plasma Therapy
12.6.4 Immunotherapy
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Children
12.10.2 Adult
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Life Support
13.6.2 Antiviral Medicine
13.6.3 Plasma Therapy
13.6.4 Immunotherapy
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Children
13.10.2 Adult
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Covid-19 Treatment Market: Competitive Dashboard
14.2 Global Covid-19 Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cadila Healthcare
14.3.2 Johnson & Johnson
14.3.3 ImmunoPrecise
14.3.4 Novartis
14.3.5 AstraZeneca
14.3.6 Cipla
14.3.7 AbbVie
14.3.8 Bayer
14.3.9 Regeneron Pharmaceuticals
14.3.10 Ascletis Pharma
14.3.11 GlaxoSmithKline
14.3.12 Gilead Sciences
14.3.13 Pharmstandard
14.3.14 Fujifilm Holdings
14.3.15 Zhejiang Hisun Pharmaceutical Co. Ltd
14.3.16 Roche
14.3.17 Sanofi
14.3.18 Pfizer
